MFDS’s plan to extend the conditional approval system for ‘new drugs’

The conditional approval system, which has been applied to pharmaceutical products that proved better or higher efficacy than existing ones, will be extended.

The Ministry of Food and Drug Safety(MFDS) announced the extended implementation of the conditional approval system that extend treatment options for patients through shortening the commercialization process from development to release.